Evidence map›Paper›PMID 38379821›Full record

ArticleRespirology case reports2024

Interstitial lung changes and persistent COVID-19 in a patient with follicular lymphoma: A case report.

Makiko Yomota, Masaru Tanaka, Takayuki Kobayashi, Masatake Kitano, Saori Ikeda, Yusuke Kanemasa, Noriyo Yanagawa, Yukio Hosomi

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Respirology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Makiko YomotaDepartment of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan.ORCID https://orcid.org/0000-0002-1616-9893
Masaru TanakaDepartment of Infectious Diseases Tokyo Metropolitan Komagome Hospital Tokyo Japan.
Takayuki KobayashiDepartment of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan.
Masatake KitanoDepartment of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan.
Saori IkedaDepartment of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan.
Yusuke KanemasaDepartment of Oncology Tokyo Metropolitan Komagome Hospital Tokyo Japan.
Noriyo YanagawaDepartment of Radiology Tokyo Metropolitan Komagome Hospital Tokyo Japan.
Yukio HosomiDepartment of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a case of interstitial lung changes in a patient with prolonged coronavirus disease 2019 (COVID-19) with follicular lymphoma receiving rituximab and bendamustine who recovered after treatment with a combination therapy consisting of corticosteroids and immunosuppressive agents. There is currently no treatment strategy for prolonged pneumonitis following COVID-19, which can be life-threatening for immunocompromised patients. Thus, further investigation is warranted.

Indexed as

COVID‐19lymphomapneumonitistacrolimus

Identifiers

PMID38379821
PMCPMC10878828

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.